DJIA 18,010.68 -115.44 -0.64%
NASDAQ 5,070.03 -27.95 -0.55%
S&P 500 2,107.39 -13.40 -0.63%
market minute promo

Exelixis (NASDAQ: EXEL)

3.15 0.02 (0.64%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

EXEL $3.15 0.64%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.19
Previous Close $3.13
Daily Range $3.13 - $3.22
52-Week Range $1.26 - $4.55
Market Cap $617.5M
P/E Ratio -2.68
Dividend (Yield) $0.00 (0.0%)
Volume 1,646,402
Average Daily Volume 3,602,156
Current FY EPS -$0.78

Sector

Healthcare

Industry

Drug Makers

Exelixis (EXEL) Description

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. Website: http://www.exelixis.com/

News & Commentary Rss Feed

Biotech Investment Opportunities for the Long Term

Biotech stocks have a history of outperforming the broad-market indexes -- if you pick the right ones. Here are three biotech investment opportunities for the long term that you should be considering.

3 Stocks That Could Double Your Money

Biotech has produced numerous stocks recently that have doubled or tripled in short periods of time. Here is a look at three small-cap companies with the potential to continue this trend.

Buy More Disney - Cramer's Lightning Round (5/22/15)

'Mad Money' Lightning Round: Buy Disney, Be Careful With Exelixis

Stifel Talks 5 Biotech Stocks

Exelixis (EXEL) Worth Watching: Stock Moves 10.3% Higher - Tale of the Tape

Exelixis (EXEL) Stock Spikes on First Quarter Earnings Report

You'll Never Guess Why Exelixis, Inc. Romped 14% Higher

Exelixis soars 14% after the company reports better-than-expected first-quarter results, but is something else in its report responsible for today's monstrous gains?

Waiting for Exelixis, Inc.'s Meteor to Land

Data from the biotech's kidney cancer trial won't be available until late in the second quarter or potentially even later.

Exelixis' (EXEL) CEO Mike Morrissey on Q1 2015 Results - Earnings Call Transcript

See More EXEL News...

EXEL's Top Competitors

EXEL $3.15 (0.64%)
Current stock: EXEL
TMO $129.63 (-0.38%)
Current stock: TMO
ILMN $206.08 (-1.22%)
Current stock: ILMN
WAT $133.62 (-0.71%)
Current stock: WAT